Mpox (Monkeypox): Virology, Symptoms, Transmission, Treatment, Prevention, and Global Health Impact

Mpox: Virology, Symptoms, Transmission, Treatment, Prevention, and Global Health Impact

Mpox, previously known as monkeypox, is a rare but significant viral disease that affects humans and other animals. It is caused by the mpox virus, a member of the orthopoxvirus genus, which also includes variola virus (the cause of smallpox), vaccinia virus (used in the smallpox vaccine), and cowpox virus. This comprehensive guide covers the origin, epidemiology, transmission, symptoms, diagnosis, treatment, prevention, and public health implications of mpox, as well as the impact of the disease on global health.

 

Introduction

Mpox was first discovered in 1958 when two outbreaks occurred in colonies of monkeys kept for research, leading to its initial name "monkeypox." However, the first human case was recorded in 1970 in the Democratic Republic of the Congo (DRC). Although the disease is called "mpox," it is important to note that the primary animal reservoirs are not monkeys but rodents, particularly in Africa.

Virology

The mpox virus is an enveloped double-stranded DNA virus, part of the orthopoxvirus genus within the Poxviridae family. The virus is relatively large and complex, containing its own machinery for replication, which occurs in the cytoplasm of infected cells. The mpox virus is closely related to the variola virus, sharing several structural and genetic similarities.

 

Epidemiology

Mpox is endemic to Central and West Africa, particularly in rural areas where people are in close contact with wild animals. The disease has been reported in several African countries, including the DRC, Nigeria, Cameroon, and the Central African Republic. Although mpox is a zoonotic disease, it can spread from animals to humans and between humans.

Emerging Global Threat

In recent years, mpox has become an emerging global health threat due to outbreaks outside of Africa. Notably, an outbreak in the United States in 2003 was linked to imported African rodents. The global concern increased with the spread of the virus in 2022, which led to its reclassification as "mpox" by the World Health Organization (WHO) to reduce stigma associated with the original name.

Mpox Transmission

Transmission of mpox can occur through various methods, both from person-to-person and animal-to-human. Below is a concise breakdown of how the virus spreads:

1. Person-to-Person Transmission

• Direct Contact with Lesions: Contact with infectious skin lesions, including those in the mouth or genitals.
• Face-to-Face Contact: Talking or breathing close to an infected person.
• Skin-to-Skin Contact: Physical contact, including vaginal/anal sex.
• Mouth-to-Mouth Contact: Kissing.
• Mouth-to-Skin Contact: Oral sex or kissing the skin.
• Respiratory Droplets or Short-Range Aerosols: Prolonged close contact can transmit the virus via droplets or aerosols.
• Entry Points: The virus enters through broken skin, mucosal surfaces (oral, pharyngeal, ocular, genital, anorectal), or the respiratory tract.
• Household and Sexual Transmission: The virus can spread to household members or sex partners, especially those with multiple sexual partners.

2. Animal-to-Human Transmission

• Bites or Scratches: Transmission from infected animals through bites or scratches.
• Handling Infected Animals: Activities like hunting, skinning, trapping, cooking, or handling carcasses can result in transmission.
• Viral Circulation in Animals: The extent of viral circulation in animal populations is still being studied.

3. Indirect Transmission

• Contaminated Objects: Clothing, linens, or contaminated materials.
• Sharps Injuries: Health care workers are at risk through sharps injuries.
• Community Settings: Potential exposure in places like tattoo parlours.

Signs and Symptoms of Mpox

Mpox presents with a range of signs and symptoms that usually begin within one week of exposure but may take anywhere from 1 to 21 days to appear. The duration of symptoms generally lasts between 2 to 4 weeks, though it can extend longer in individuals with weakened immune systems.

Common Symptoms of Mpox:

• Rash
• Fever
• Sore throat
• Headache
• Muscle aches
• Back pain
• Low energy
• Swollen lymph nodes

Initial Symptoms

The onset of symptoms can vary from person to person. For some, a rash might be the first noticeable symptom, while others may experience fever, muscle aches, and sore throat before any rash appears. The rash often starts as flat sores which then evolve into blisters filled with fluid. These blisters may be itchy or painful. As the disease progresses, the lesions dry out, form crusts, and eventually fall off.

The rash associated with mpox can vary significantly in severity. Some individuals may only have a few lesions, while others could develop hundreds or more. These lesions can appear on various parts of the body, including:

• Palms of the hands and soles of the feet
• Face, mouth, and throat
• Groin and genital areas
• Anus

In some cases, the rash may cause significant discomfort, leading to painful swelling of the rectum or difficulty urinating.

Contagious Period

Individuals with mpox are contagious until all the sores have healed and a new layer of skin has formed over the affected areas. During this period, they can transmit the virus to others through direct contact with the lesions or bodily fluids.

Vulnerable Populations

Certain groups are more vulnerable to complications from mpox. These include:

• Children
• Pregnant individuals
• People with weakened immune systems

Progression of Symptoms

Typically, fever, muscle aches, and sore throat are the initial signs of mpox. The rash then begins on the face and gradually spreads to other parts of the body, including the palms of the hands and soles of the feet. This rash undergoes a series of stages over the course of 2 to 4 weeks:

1. Macules: Flat lesions
2. Papules: Raised lesions
3. Vesicles: Blisters filled with clear fluid
4. Pustules: Blisters filled with pus

The pustules eventually dip in the center and begin to crust over. As the lesions heal, scabs form and eventually fall off, leaving new skin underneath. Swollen lymph nodes (lymphadenopathy) are a classic feature of mpox and help distinguish it from similar viral infections.

Global Outbreak (2022) and Clade IIb Virus

In the global outbreak of mpox that began in 2022, primarily caused by the Clade IIb virus, the disease has shown some differences in presentation. For over half of the affected individuals, the rash may appear before or simultaneously with other symptoms and does not always spread across the body. The first lesions may appear in areas such as the groin, anus, or mouth.

Complications of Mpox

While most cases of mpox resolve without severe consequences, some individuals can experience serious complications, particularly those with compromised immune systems. Potential complications include:

• Bacterial skin infections: These can lead to abscesses or significant skin damage.
• Pneumonia
• Corneal infections: These can result in vision loss.
• Gastrointestinal issues: Difficulty swallowing, vomiting, and diarrhea can lead to dehydration and malnutrition.
• Sepsis: A widespread infection in the bloodstream accompanied by inflammation.
• Encephalitis: Inflammation of the brain.
• Myocarditis: Inflammation of the heart.
• Proctitis: Inflammation of the rectum.
• Balanitis: Inflammation of the genital organs.
• Urethritis: Inflammation of the urinary passages.

Individuals living with untreated or poorly controlled HIV are at increased risk of developing severe mpox and its associated complications.

Self-Care and Prevention of Mpox

Most individuals with mpox will recover within 2 to 4 weeks. To alleviate symptoms and prevent the spread of the virus to others, following proper self-care and preventive measures is essential.

Self-Care Recommendations

• Stay Home: Remain in your own room as much as possible to minimize the risk of transmitting the virus to others.
• Hand Hygiene: Wash your hands frequently with soap and water or use hand sanitizer, particularly before and after touching sores.
• Wear a Mask: Use a mask and cover any lesions when around other people until your rash has completely healed.
• Keep Skin Dry: Keep your skin dry and uncovered, unless you are in a room with someone else, to promote healing and prevent further infection.
• Disinfect Shared Spaces: Avoid touching items in shared spaces. Disinfect these areas frequently to reduce the risk of transmission.
• Saltwater Rinses: For sores in the mouth, use saltwater rinses to soothe irritation.
• Baths: Take sitz baths or warm baths with baking soda or Epsom salts to alleviate discomfort from body sores.
• Pain Relief: Use over-the-counter pain medications like paracetamol (acetaminophen) or ibuprofen to manage pain.

What to Avoid

• Do Not Pop Blisters: Avoid popping blisters or scratching sores. This can hinder the healing process, spread the rash to other parts of your body, and lead to secondary infections.
• Avoid Shaving: Do not shave areas with sores until scabs have healed and new skin has formed. Shaving can spread the rash to other areas.

Preventing the Spread of Mpox

• Isolation: Isolate yourself at home or in a hospital if necessary for the duration of the infectious period. This period begins at the onset of symptoms and continues until all lesions have healed and scabs have fallen off.
• Cover Lesions and Wear a Mask: Covering your lesions and wearing a medical mask when around others can help prevent the spread of the virus.
• Use Condoms: During sexual activity, use condoms to reduce the risk of transmitting mpox. However, condoms do not fully prevent transmission from skin-to-skin or mouth-to-skin contact.

By adhering to these self-care and preventive measures, you can manage the symptoms of mpox effectively and help prevent its transmission to others. Prioritizing hygiene, isolation, and careful handling of lesions are key to a quicker recovery and reducing the impact of this disease on those around you

Diagnosis

Diagnosis of mpox is primarily based on clinical presentation, particularly the characteristic rash and history of exposure to infected animals or individuals. However, laboratory tests are essential for confirmation.

Laboratory Testing

• Polymerase Chain Reaction (PCR): This is the preferred method for detecting mpox virus DNA from lesion swabs. It is highly specific and sensitive.
• Electron Microscopy: While less commonly used, electron microscopy can visualize the virus particles in lesion samples.
• Serology: Antibody detection can help in understanding exposure history but is not typically used for acute diagnosis.
• Viral Culture: Isolation of the virus from clinical specimens can confirm the diagnosis, but it is time-consuming and requires specialized laboratories.

Treatment

There is no specific antiviral treatment for mpox, but several supportive and symptomatic treatments can be used to manage the disease.

Supportive Care

• Fluid Replacement: Ensuring adequate hydration is crucial, particularly in patients with severe disease or complications.
• Pain Management: Analgesics can be used to alleviate pain associated with lesions and other symptoms.
• Antibiotics: Secondary bacterial infections should be treated with appropriate antibiotics.

Antiviral Therapies

• Tecovirimat: This antiviral drug, originally developed for smallpox, has shown efficacy against mpox in animal studies and is available under certain conditions.
• Cidofovir and Brincidofovir: These antiviral agents have activity against orthopoxviruses and may be considered for severe cases, though their use is limited by potential side effects.

Prevention

Preventing mpox involves a combination of public health measures, vaccination, and individual precautions.

Vaccination

• Smallpox Vaccine: The smallpox vaccine, which uses the vaccinia virus, provides cross-protection against mpox. Mass vaccination campaigns have historically contributed to the control of mpox outbreaks.
• New Vaccines: More recent vaccines, such as the Modified Vaccinia Ankara (MVA) vaccine, are safer and have been developed specifically with mpox in mind.

Public Health Measures

• Surveillance: Monitoring and reporting of mpox cases are crucial for early detection and containment of outbreaks.
• Quarantine and Isolation: Infected individuals should be isolated to prevent transmission, and close contacts may be quarantined and monitored for symptoms.
• Education and Awareness: Public education campaigns can help people understand the risks of mpox and how to protect themselves.

Personal Precautions

• Avoid Contact with Wild Animals: Reducing contact with potentially infected animals, particularly in endemic areas, is important.
• Safe Food Practices: Avoiding the consumption of bushmeat and practicing good food hygiene can reduce the risk of infection.
• Hygiene: Regular handwashing and use of personal protective equipment (PPE) when caring for infected individuals can prevent transmission.

Global Health Impact

Mpox, while less deadly than smallpox, remains a significant public health concern, particularly in endemic regions. The recent spread of mpox to non-endemic areas highlights the potential for global outbreaks and underscores the need for international cooperation in surveillance, research, and response efforts.

Public Health Challenges

• Resource Limitations: Many countries where mpox is endemic face challenges such as limited healthcare infrastructure, which complicates efforts to control outbreaks.
• Stigmatization: The name "monkeypox" has contributed to stigma and misinformation, leading to the WHO's decision to rebrand the disease as "mpox" in 2022.
• Vaccine Hesitancy: Despite the availability of vaccines, vaccine hesitancy remains a barrier to effective prevention, particularly in regions with low trust in public health authorities.

Research and Development

• Vaccine Development: Ongoing research is focused on developing safer and more effective vaccines for mpox, including those suitable for immunocompromised individuals.
• Antiviral Therapies: Continued research into antiviral drugs may provide more treatment options for severe cases of mpox.
• Zoonotic Disease Surveillance: Improving surveillance of zoonotic diseases like mpox is critical for early detection and prevention of future outbreaks.

Conclusion

Mpox is a re-emerging zoonotic disease that poses a significant public health threat, particularly in endemic regions of Central and West Africa. While it is generally less severe than smallpox, mpox can cause serious complications and even death, particularly in vulnerable populations. With the increasing incidence of global outbreaks, there is a pressing need for international cooperation in surveillance, research, and prevention efforts. Vaccination, public health measures, and education will play critical roles in controlling the spread of the disease and minimizing its impact on global health.

Share this

Earthisone